<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38388736</PMID><DateCompleted><Year>2024</Year><Month>03</Month><Day>08</Day></DateCompleted><DateRevised><Year>2024</Year><Month>04</Month><Day>19</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1546-1726</ISSN><JournalIssue CitedMedium="Internet"><Volume>27</Volume><Issue>3</Issue><PubDate><Year>2024</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Nature neuroscience</Title><ISOAbbreviation>Nat Neurosci</ISOAbbreviation></Journal><ArticleTitle>Blood-brain barrier disruption and sustained systemic inflammation in individuals with long COVID-associated cognitive impairment.</ArticleTitle><Pagination><StartPage>421</StartPage><EndPage>432</EndPage><MedlinePgn>421-432</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41593-024-01576-9</ELocationID><Abstract><AbstractText>Vascular disruption has been implicated in coronavirus disease 2019 (COVID-19) pathogenesis and may predispose to the neurological sequelae associated with long COVID, yet it is unclear how blood-brain barrier (BBB) function is affected in these conditions. Here we show that BBB disruption is evident during acute infection and in patients with long COVID with cognitive impairment, commonly referred to as brain fog. Using dynamic contrast-enhanced magnetic resonance imaging, we show BBB disruption in patients with long COVID-associated brain fog. Transcriptomic analysis of peripheral blood mononuclear cells revealed dysregulation of the coagulation system and a dampened adaptive immune response in individuals with brain fog. Accordingly, peripheral blood mononuclear cells showed increased adhesion to human brain endothelial cells in vitro, while exposure of brain endothelial cells to serum from patients with long COVID induced expression of inflammatory markers. Together, our data suggest that sustained systemic inflammation and persistent localized BBB dysfunction is a key feature of long COVID-associated brain fog.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Greene</LastName><ForeName>Chris</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0003-4192-9433</Identifier><AffiliationInfo><Affiliation>Smurfit Institute of Genetics, Trinity College Dublin, Dublin, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Connolly</LastName><ForeName>Ruairi</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Neurology, Health Care Centre, St James's Hospital, Dublin, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brennan</LastName><ForeName>Declan</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Neurology, Health Care Centre, St James's Hospital, Dublin, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Laffan</LastName><ForeName>Aoife</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurology, Health Care Centre, St James's Hospital, Dublin, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>O'Keeffe</LastName><ForeName>Eoin</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Smurfit Institute of Genetics, Trinity College Dublin, Dublin, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zaporojan</LastName><ForeName>Lilia</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Neurology, Health Care Centre, St James's Hospital, Dublin, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>O'Callaghan</LastName><ForeName>Jeffrey</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0001-8818-4331</Identifier><AffiliationInfo><Affiliation>Smurfit Institute of Genetics, Trinity College Dublin, Dublin, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thomson</LastName><ForeName>Bennett</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Smurfit Institute of Genetics, Trinity College Dublin, Dublin, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Connolly</LastName><ForeName>Emma</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>The Irish Longitudinal Study on Ageing, School of Medicine, Trinity College Dublin, Dublin, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Argue</LastName><ForeName>Ruth</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Clinical Research Facility, St James's Hospital, Dublin, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meaney</LastName><ForeName>James F M</ForeName><Initials>JFM</Initials><AffiliationInfo><Affiliation>Thomas Mitchell Centre for Advanced Medical Imaging (CAMI), St. James's Hospital &amp; Trinity College Dublin, Dublin, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martin-Loeches</LastName><ForeName>Ignacio</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, Multidisciplinary Intensive Care Research Organization, Trinity Centre for Health Sciences, St James's University Hospital, Dublin, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Long</LastName><ForeName>Aideen</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Trinity Translational Medicine Institute, Trinity College Dublin, St James's Hospital, Dublin, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cheallaigh</LastName><ForeName>Cliona Ni</ForeName><Initials>CN</Initials><AffiliationInfo><Affiliation>Trinity Translational Medicine Institute, Trinity College Dublin, St James's Hospital, Dublin, Ireland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Immunology, St James's Hospital, Dublin, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Conlon</LastName><ForeName>Niall</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Immunology, St James's Hospital, Dublin, Ireland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>St James's Hospital, Tallaght University Hospital, Trinity College Dublin Allied Researchers (STTAR) Bioresource, Trinity College Dublin, Dublin, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Doherty</LastName><ForeName>Colin P</ForeName><Initials>CP</Initials><Identifier Source="ORCID">0000-0002-8869-8567</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Health Care Centre, St James's Hospital, Dublin, Ireland. cdohert@tcd.ie.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Academic Unit of Neurology, Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland. cdohert@tcd.ie.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>FutureNeuro, Science Foundation Ireland Research Centre for Chronic and Rare Neurological Diseases, Royal College of Surgeons in Ireland, University of Medicine and Health Sciences, Dublin, Ireland. cdohert@tcd.ie.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Campbell</LastName><ForeName>Matthew</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-3325-240X</Identifier><AffiliationInfo><Affiliation>Smurfit Institute of Genetics, Trinity College Dublin, Dublin, Ireland. matthew.campbell@tcd.ie.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>FutureNeuro, Science Foundation Ireland Research Centre for Chronic and Rare Neurological Diseases, Royal College of Surgeons in Ireland, University of Medicine and Health Sciences, Dublin, Ireland. matthew.campbell@tcd.ie.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>20/COV/0312</GrantID><Agency>Science Foundation Ireland (SFI)</Agency><Country/></Grant><Grant><GrantID>21/SPP/3732</GrantID><Agency>Science Foundation Ireland (SFI)</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>02</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Nat Neurosci</MedlineTA><NlmUniqueID>9809671</NlmUniqueID><ISSNLinking>1097-6256</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>Nat Neurosci. 2024 May;27(5):1019. doi: 10.1038/s41593-024-01644-0</RefSource><PMID Version="1">38627595</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001812" MajorTopicYN="N">Blood-Brain Barrier</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D042783" MajorTopicYN="N">Endothelial Cells</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007963" MajorTopicYN="N">Leukocytes, Mononuclear</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D060825" MajorTopicYN="Y">Cognitive Dysfunction</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005222" MajorTopicYN="N">Mental Fatigue</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>11</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>1</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>3</Month><Day>8</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>2</Month><Day>23</Day><Hour>0</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>2</Month><Day>22</Day><Hour>23</Hour><Minute>50</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>2</Month><Day>22</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38388736</ArticleId><ArticleId IdType="pmc">PMC10917679</ArticleId><ArticleId IdType="doi">10.1038/s41593-024-01576-9</ArticleId><ArticleId IdType="pii">10.1038/s41593-024-01576-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020;323:1239&#x2013;1242. doi: 10.1001/jama.2020.2648.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.2648</ArticleId><ArticleId IdType="pubmed">32091533</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu N, et al. A novel coronavirus from patients with pneumonia in China, 2019. N. Engl. J. Med. 2020;382:727&#x2013;733. doi: 10.1056/NEJMoa2001017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2001017</ArticleId><ArticleId IdType="pmc">PMC7092803</ArticleId><ArticleId IdType="pubmed">31978945</ArticleId></ArticleIdList></Reference><Reference><Citation>Helms J, et al. Neurologic features in severe SARS-CoV-2 infection. N. Engl. J. Med. 2020;382:2268&#x2013;2270. doi: 10.1056/NEJMc2008597.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2008597</ArticleId><ArticleId IdType="pmc">PMC7179967</ArticleId><ArticleId IdType="pubmed">32294339</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Geddes JR, Husain M, Luciano S, Harrison PJ. 6-month neurological and psychiatric outcomes in 236&#x2009;379 survivors of COVID-19: a retrospective cohort study using electronic health records. Lancet Psychiatry. 2021;8:416&#x2013;427. doi: 10.1016/S2215-0366(21)00084-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(21)00084-5</ArticleId><ArticleId IdType="pmc">PMC8023694</ArticleId><ArticleId IdType="pubmed">33836148</ArticleId></ArticleIdList></Reference><Reference><Citation>Bohmwald K, G&#xe1;lvez NMS, R&#xed;os M, Kalergis AM. Neurologic alterations due to respiratory virus infections. Front. Cell. Neurosci. 2018;12:386. doi: 10.3389/fncel.2018.00386.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2018.00386</ArticleId><ArticleId IdType="pmc">PMC6212673</ArticleId><ArticleId IdType="pubmed">30416428</ArticleId></ArticleIdList></Reference><Reference><Citation>Amraei R, et al. Extracellular vimentin is an attachment factor that facilitates SARS-CoV-2 entry into human endothelial cells. Proc. Natl Acad. Sci. USA. 2022;119:e2113874119. doi: 10.1073/pnas.2113874119.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2113874119</ArticleId><ArticleId IdType="pmc">PMC8833221</ArticleId><ArticleId IdType="pubmed">35078919</ArticleId></ArticleIdList></Reference><Reference><Citation>Cantuti-Castelvetri L, et al. Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity. Science. 2020;370:856&#x2013;860. doi: 10.1126/science.abd2985.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abd2985</ArticleId><ArticleId IdType="pmc">PMC7857391</ArticleId><ArticleId IdType="pubmed">33082293</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann M, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181:271&#x2013;280. doi: 10.1016/j.cell.2020.02.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.02.052</ArticleId><ArticleId IdType="pmc">PMC7102627</ArticleId><ArticleId IdType="pubmed">32142651</ArticleId></ArticleIdList></Reference><Reference><Citation>Ni W, et al. Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19. Crit. Care. 2020;24:422. doi: 10.1186/s13054-020-03120-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-020-03120-0</ArticleId><ArticleId IdType="pmc">PMC7356137</ArticleId><ArticleId IdType="pubmed">32660650</ArticleId></ArticleIdList></Reference><Reference><Citation>Vanlandewijck M, et al. A molecular atlas of cell types and zonation in the brain vasculature. Nature. 2018;554:475&#x2013;480. doi: 10.1038/nature25739.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature25739</ArticleId><ArticleId IdType="pubmed">29443965</ArticleId></ArticleIdList></Reference><Reference><Citation>Iadecola C, Anrather J, Kamel H. Effects of COVID-19 on the nervous system. Cell. 2020;183:16&#x2013;27. doi: 10.1016/j.cell.2020.08.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.08.028</ArticleId><ArticleId IdType="pmc">PMC7437501</ArticleId><ArticleId IdType="pubmed">32882182</ArticleId></ArticleIdList></Reference><Reference><Citation>Lersy F, et al. Cerebrospinal fluid features in patients with coronavirus disease 2019 and neurological manifestations: correlation with brain magnetic resonance imaging findings in 58 patients. J. Infect. Dis. 2021;223:600&#x2013;609. doi: 10.1093/infdis/jiaa745.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiaa745</ArticleId><ArticleId IdType="pmc">PMC7798956</ArticleId><ArticleId IdType="pubmed">33249438</ArticleId></ArticleIdList></Reference><Reference><Citation>Schweitzer F, et al. Cerebrospinal fluid analysis post-COVID-19 is not suggestive of persistent central nervous system infection. Ann. Neurol. 2022;91:150&#x2013;157. doi: 10.1002/ana.26262.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.26262</ArticleId><ArticleId IdType="pmc">PMC8653324</ArticleId><ArticleId IdType="pubmed">34724243</ArticleId></ArticleIdList></Reference><Reference><Citation>Thakur KT, et al. COVID-19 neuropathology at Columbia University Irving Medical Center/New York Presbyterian Hospital. Brain. 2021;144:2696&#x2013;2708. doi: 10.1093/brain/awab148.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awab148</ArticleId><ArticleId IdType="pmc">PMC8083258</ArticleId><ArticleId IdType="pubmed">33856027</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang AC, et al. Dysregulation of brain and choroid plexus cell types in severe COVID-19. Nature. 2021;595:565&#x2013;571. doi: 10.1038/s41586-021-03710-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03710-0</ArticleId><ArticleId IdType="pmc">PMC8400927</ArticleId><ArticleId IdType="pubmed">34153974</ArticleId></ArticleIdList></Reference><Reference><Citation>Stein SR, et al. SARS-CoV-2 infection and persistence in the human body and brain at autopsy. Nature. 2022;612:758&#x2013;763. doi: 10.1038/s41586-022-05542-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-05542-y</ArticleId><ArticleId IdType="pmc">PMC9749650</ArticleId><ArticleId IdType="pubmed">36517603</ArticleId></ArticleIdList></Reference><Reference><Citation>Monje M, Iwasaki A. The neurobiology of long COVID. Neuron. 2022;110:3484&#x2013;3496. doi: 10.1016/j.neuron.2022.10.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2022.10.006</ArticleId><ArticleId IdType="pmc">PMC9537254</ArticleId><ArticleId IdType="pubmed">36288726</ArticleId></ArticleIdList></Reference><Reference><Citation>Natale NR, Lukens JR, Petri WA., Jr The nervous system during COVID-19: caught in the crossfire. Immunol. Rev. 2022;311:90&#x2013;111. doi: 10.1111/imr.13114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imr.13114</ArticleId><ArticleId IdType="pmc">PMC9350403</ArticleId><ArticleId IdType="pubmed">35770683</ArticleId></ArticleIdList></Reference><Reference><Citation>Abbott NJ, Patabendige AA, Dolman DEM, Yusof SR, Begley DJ. Structure and function of the blood&#x2013;brain barrier. Neurobiol. Dis. 2010;37:13&#x2013;25. doi: 10.1016/j.nbd.2009.07.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2009.07.030</ArticleId><ArticleId IdType="pubmed">19664713</ArticleId></ArticleIdList></Reference><Reference><Citation>Greene C, Hanley N, Campbell M. Claudin-5: gatekeeper of neurological function. Fluids Barriers CNS. 2019;16:3. doi: 10.1186/s12987-019-0123-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12987-019-0123-z</ArticleId><ArticleId IdType="pmc">PMC6350359</ArticleId><ArticleId IdType="pubmed">30691500</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee M-H, et al. Microvascular injury in the brains of patients with Covid-19. N. Engl. J. Med. 2021;384:481&#x2013;483. doi: 10.1056/NEJMc2033369.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2033369</ArticleId><ArticleId IdType="pmc">PMC7787217</ArticleId><ArticleId IdType="pubmed">33378608</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee MH, et al. Neurovascular injury with complement activation and inflammation in COVID-19. Brain. 2022;145:2555&#x2013;2568. doi: 10.1093/brain/awac151.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awac151</ArticleId><ArticleId IdType="pmc">PMC9278212</ArticleId><ArticleId IdType="pubmed">35788639</ArticleId></ArticleIdList></Reference><Reference><Citation>DeOre BJ, Tran KA, Andrews AM, Ramirez SH, Galie PA. SARS-CoV-2 spike protein disrupts blood&#x2013;brain barrier integrity via RhoA activation. J. Neuroimmune Pharmacol. 2021;16:722&#x2013;728. doi: 10.1007/s11481-021-10029-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11481-021-10029-0</ArticleId><ArticleId IdType="pmc">PMC8536479</ArticleId><ArticleId IdType="pubmed">34687399</ArticleId></ArticleIdList></Reference><Reference><Citation>Krasemann S, et al. The blood&#x2013;brain barrier is dysregulated in COVID-19 and serves as a CNS entry route for SARS-CoV-2. Stem Cell Reports. 2022;17:307&#x2013;320. doi: 10.1016/j.stemcr.2021.12.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2021.12.011</ArticleId><ArticleId IdType="pmc">PMC8772030</ArticleId><ArticleId IdType="pubmed">35063125</ArticleId></ArticleIdList></Reference><Reference><Citation>Pellegrini, L. et al. SARS-CoV-2 infects the brain choroid plexus and disrupts the blood&#x2013;CSF barrier in human brain organoids. Cell Stem Cell27, 951&#x2013;961.e5 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7553118</ArticleId><ArticleId IdType="pubmed">33113348</ArticleId></ArticleIdList></Reference><Reference><Citation>Savarraj J, et al. Brain injury, endothelial injury and inflammatory markers are elevated and express sex-specific alterations after COVID-19. J. Neuroinflammation. 2021;18:277. doi: 10.1186/s12974-021-02323-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-021-02323-8</ArticleId><ArticleId IdType="pmc">PMC8627162</ArticleId><ArticleId IdType="pubmed">34838058</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwabenland M, et al. Deep spatial profiling of human COVID-19 brains reveals neuroinflammation with distinct microanatomical microglia-T-cell interactions. Immunity. 2021;54:1594&#x2013;1610. doi: 10.1016/j.immuni.2021.06.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2021.06.002</ArticleId><ArticleId IdType="pmc">PMC8188302</ArticleId><ArticleId IdType="pubmed">34174183</ArticleId></ArticleIdList></Reference><Reference><Citation>Wenzel J, et al. The SARS-CoV-2 main protease Mpro causes microvascular brain pathology by cleaving NEMO in brain endothelial cells. Nat. Neurosci. 2021;24:1522&#x2013;1533. doi: 10.1038/s41593-021-00926-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-021-00926-1</ArticleId><ArticleId IdType="pmc">PMC8553622</ArticleId><ArticleId IdType="pubmed">34675436</ArticleId></ArticleIdList></Reference><Reference><Citation>Montalvan V, Lee J, Bueso T, De Toledo J, Rivas K. Neurological manifestations of COVID-19 and other coronavirus infections: a systematic review. Clin. Neurol. Neurosurg. 2020;194:105921. doi: 10.1016/j.clineuro.2020.105921.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clineuro.2020.105921</ArticleId><ArticleId IdType="pmc">PMC7227498</ArticleId><ArticleId IdType="pubmed">32422545</ArticleId></ArticleIdList></Reference><Reference><Citation>Ng Kee Kwong, K. C., Mehta, P. R., Shukla, G. &amp; Mehta, A. R. COVID-19, SARS and MERS: a neurological perspective. J. Clin. Neurosci.77, 13&#x2013;16 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7198407</ArticleId><ArticleId IdType="pubmed">32417124</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Doherty L, et al. Study protocol for the St James&#x2019;s Hospital, Tallaght University Hospital, Trinity College Dublin Allied Researchers&#x2019; (STTAR) Bioresource for COVID-19. HRB Open Res. 2022;5:20. doi: 10.12688/hrbopenres.13498.1.</Citation><ArticleIdList><ArticleId IdType="doi">10.12688/hrbopenres.13498.1</ArticleId><ArticleId IdType="pmc">PMC9111362</ArticleId><ArticleId IdType="pubmed">35615437</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryan FJ, et al. Long-term perturbation of the peripheral immune system months after SARS-CoV-2 infection. BMC Med. 2022;20:26. doi: 10.1186/s12916-021-02228-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-021-02228-6</ArticleId><ArticleId IdType="pmc">PMC8758383</ArticleId><ArticleId IdType="pubmed">35027067</ArticleId></ArticleIdList></Reference><Reference><Citation>Finlay, J. B. et al. Persistent post&#x2013;COVID-19 smell loss is associated with immune cell infiltration and altered gene expression in olfactory epithelium. Sci. Transl. Med.14, eadd0484 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10317309</ArticleId><ArticleId IdType="pubmed">36542694</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou G, Lane G, Cooper SL, Kahnt T, Zelano C. Characterizing functional pathways of the human olfactory system. eLife. 2019;8:e47177. doi: 10.7554/eLife.47177.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.47177</ArticleId><ArticleId IdType="pmc">PMC6656430</ArticleId><ArticleId IdType="pubmed">31339489</ArticleId></ArticleIdList></Reference><Reference><Citation>Saive A-L, Royet J-P, Plailly J. A review on the neural bases of episodic odor memory: from laboratory-based to autobiographical approaches. Front. Behav. Neurosci. 2014;8:240. doi: 10.3389/fnbeh.2014.00240.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnbeh.2014.00240</ArticleId><ArticleId IdType="pmc">PMC4083449</ArticleId><ArticleId IdType="pubmed">25071494</ArticleId></ArticleIdList></Reference><Reference><Citation>Phetsouphanh C, et al. Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection. Nat. Immunol. 2022;23:210&#x2013;216. doi: 10.1038/s41590-021-01113-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01113-x</ArticleId><ArticleId IdType="pubmed">35027728</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng H-Y, et al. Longitudinal transcriptome analyses show robust T cell immunity during recovery from COVID-19. Signal Transduct. Target. Ther. 2020;5:294. doi: 10.1038/s41392-020-00457-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-020-00457-4</ArticleId><ArticleId IdType="pmc">PMC7758413</ArticleId><ArticleId IdType="pubmed">33361761</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, et al. Acute blood biomarker profiles predict cognitive deficits 6 and 12 months after COVID-19 hospitalization. Nat. Med. 2023;29:2498&#x2013;2508. doi: 10.1038/s41591-023-02525-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-023-02525-y</ArticleId><ArticleId IdType="pmc">PMC10579097</ArticleId><ArticleId IdType="pubmed">37653345</ArticleId></ArticleIdList></Reference><Reference><Citation>Douaud G, et al. SARS-CoV-2 is associated with changes in brain structure in UK Biobank. Nature. 2022;604:697&#x2013;707. doi: 10.1038/s41586-022-04569-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04569-5</ArticleId><ArticleId IdType="pmc">PMC9046077</ArticleId><ArticleId IdType="pubmed">35255491</ArticleId></ArticleIdList></Reference><Reference><Citation>Donegani MI, et al. Brain metabolic correlates of persistent olfactory dysfunction after SARS-Cov2 infection. Biomedicines. 2021;9:287. doi: 10.3390/biomedicines9030287.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines9030287</ArticleId><ArticleId IdType="pmc">PMC7998481</ArticleId><ArticleId IdType="pubmed">33808956</ArticleId></ArticleIdList></Reference><Reference><Citation>Fitsiori A, Pugin D, Thieffry C, Lalive P, Vargas MI. COVID-19 is associated with an unusual pattern of brain microbleeds in critically ill patients. J. Neuroimaging. 2020;30:593&#x2013;597. doi: 10.1111/jon.12755.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jon.12755</ArticleId><ArticleId IdType="pmc">PMC7361874</ArticleId><ArticleId IdType="pubmed">32639679</ArticleId></ArticleIdList></Reference><Reference><Citation>Guedj E, et al. 18F-FDG brain PET hypometabolism in patients with long COVID. Eur. J. Nucl. Med. Mol. Imaging. 2021;48:2823&#x2013;2833. doi: 10.1007/s00259-021-05215-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-021-05215-4</ArticleId><ArticleId IdType="pmc">PMC7837643</ArticleId><ArticleId IdType="pubmed">33501506</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin Y, et al. Long-term microstructure and cerebral blood flow changes in patients recovered from COVID-19 without neurological manifestations. J. Clin. Invest. 2021;131:e147329. doi: 10.1172/JCI147329.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI147329</ArticleId><ArticleId IdType="pmc">PMC8262559</ArticleId><ArticleId IdType="pubmed">33630760</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian T, et al. Long-term follow-up of dynamic brain changes in patients recovered from COVID-19 without neurological manifestations. JCI Insight. 2022;7:e155827. doi: 10.1172/jci.insight.155827.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.155827</ArticleId><ArticleId IdType="pmc">PMC8876627</ArticleId><ArticleId IdType="pubmed">35191397</ArticleId></ArticleIdList></Reference><Reference><Citation>Aleksovska K, et al. Systematic review and meta-analysis of circulating S100B blood levels in schizophrenia. PLoS ONE. 2014;9:e106342. doi: 10.1371/journal.pone.0106342.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0106342</ArticleId><ArticleId IdType="pmc">PMC4159239</ArticleId><ArticleId IdType="pubmed">25202915</ArticleId></ArticleIdList></Reference><Reference><Citation>Thelin EP, Nelson DW, Bellander B-M. A review of the clinical utility of serum S100B protein levels in the assessment of traumatic brain injury. Acta Neurochir. 2017;159:209&#x2013;225. doi: 10.1007/s00701-016-3046-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00701-016-3046-3</ArticleId><ArticleId IdType="pmc">PMC5241347</ArticleId><ArticleId IdType="pubmed">27957604</ArticleId></ArticleIdList></Reference><Reference><Citation>Greene C, et al. Microvascular stabilization via blood&#x2013;brain barrier regulation prevents seizure activity. Nat. Commun. 2022;13:2003. doi: 10.1038/s41467-022-29657-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-29657-y</ArticleId><ArticleId IdType="pmc">PMC9010415</ArticleId><ArticleId IdType="pubmed">35422069</ArticleId></ArticleIdList></Reference><Reference><Citation>Montagne A, et al. Blood&#x2013;brain barrier breakdown in the aging human hippocampus. Neuron. 2015;85:296&#x2013;302. doi: 10.1016/j.neuron.2014.12.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2014.12.032</ArticleId><ArticleId IdType="pmc">PMC4350773</ArticleId><ArticleId IdType="pubmed">25611508</ArticleId></ArticleIdList></Reference><Reference><Citation>Senatorov VV, et al. Blood&#x2013;brain barrier dysfunction in aging induces hyperactivation of TGF&#x3b2; signaling and chronic yet reversible neural dysfunction. Sci. Transl. Med. 2019;11:eaaw8283. doi: 10.1126/scitranslmed.aaw8283.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.aaw8283</ArticleId><ArticleId IdType="pubmed">31801886</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamintsky L, et al. Blood&#x2013;brain barrier imaging as a potential biomarker for bipolar disorder progression. Neuroimage Clin. 2020;26:102049. doi: 10.1016/j.nicl.2019.102049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nicl.2019.102049</ArticleId><ArticleId IdType="pmc">PMC7229352</ArticleId><ArticleId IdType="pubmed">31718955</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamintsky L, et al. Blood&#x2013;brain barrier leakage in systemic lupus erythematosus is associated with gray matter loss and cognitive impairment. Ann. Rheum. Dis. 2020;79:1580&#x2013;1587. doi: 10.1136/annrheumdis-2020-218004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2020-218004</ArticleId><ArticleId IdType="pubmed">33004325</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdelhak A, et al. Blood GFAP as an emerging biomarker in brain and spinal cord disorders. Nat. Rev. Neurol. 2022;18:158&#x2013;172. doi: 10.1038/s41582-021-00616-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-021-00616-3</ArticleId><ArticleId IdType="pubmed">35115728</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso MJ, et al. Plasma markers of neurologic injury and inflammation in people with self-reported neurologic postacute sequelae of SARS-CoV-2 infection. Neurol. Neuroimmunol. Neuroinflamm. 2022;9:e200003. doi: 10.1212/NXI.0000000000200003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/NXI.0000000000200003</ArticleId><ArticleId IdType="pmc">PMC9210548</ArticleId><ArticleId IdType="pubmed">35701186</ArticleId></ArticleIdList></Reference><Reference><Citation>McCarthy MJ. Circadian rhythm disruption in myalgic encephalomyelitis/chronic fatigue syndrome: implications for the post-acute sequelae of COVID-19. Brain Behav. Immun. Health. 2022;20:100412. doi: 10.1016/j.bbih.2022.100412.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbih.2022.100412</ArticleId><ArticleId IdType="pmc">PMC9019698</ArticleId><ArticleId IdType="pubmed">35465246</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee WK, et al. Exogenous transforming growth factor-&#x3b2; in brain-induced symptoms of central fatigue and suppressed dopamine production in mice. Int. J. Mol. Sci. 2021;22:2580. doi: 10.3390/ijms22052580.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22052580</ArticleId><ArticleId IdType="pmc">PMC7961432</ArticleId><ArticleId IdType="pubmed">33806649</ArticleId></ArticleIdList></Reference><Reference><Citation>Montoya JG, et al. Cytokine signature associated with disease severity in chronic fatigue syndrome patients. Proc. Natl Acad. Sci. USA. 2017;114:E7150&#x2013;E7158. doi: 10.1073/pnas.1710519114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1710519114</ArticleId><ArticleId IdType="pmc">PMC5576836</ArticleId><ArticleId IdType="pubmed">28760971</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen B, Julg B, Mohandas S, Bradfute SB. Viral persistence, reactivation, and mechanisms of long COVID. eLife. 2023;12:e86015. doi: 10.7554/eLife.86015.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.86015</ArticleId><ArticleId IdType="pmc">PMC10159620</ArticleId><ArticleId IdType="pubmed">37140960</ArticleId></ArticleIdList></Reference><Reference><Citation>Proal AD, et al. SARS-CoV-2 reservoir in post-acute sequelae of COVID-19 (PASC) Nat. Immunol. 2023;24:1616&#x2013;1627. doi: 10.1038/s41590-023-01601-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-023-01601-2</ArticleId><ArticleId IdType="pubmed">37667052</ArticleId></ArticleIdList></Reference><Reference><Citation>Rong, Z. et al. SARS-CoV-2 spike protein accumulation in the skull-meninges-brain axis: potential implications for long-term neurological complications in post-COVID-19. Preprint at bioRxiv10.1101/2023.04.04.535604 (2023).</Citation></Reference><Reference><Citation>Patterson BK, et al. Persistence of SARS CoV-2 S1 protein in CD16+ monocytes in post-acute sequelae of COVID-19 (PASC) up to 15 months post-infection. Front. Immunol. 2022;12:746021. doi: 10.3389/fimmu.2021.746021.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.746021</ArticleId><ArticleId IdType="pmc">PMC8784688</ArticleId><ArticleId IdType="pubmed">35082777</ArticleId></ArticleIdList></Reference><Reference><Citation>Buzhdygan TP, et al. The SARS-CoV-2 spike protein alters barrier function in 2D static and 3D microfluidic in-vitro models of the human blood&#x2013;brain barrier. Neurobiol. Dis. 2020;146:105131. doi: 10.1016/j.nbd.2020.105131.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2020.105131</ArticleId><ArticleId IdType="pmc">PMC7547916</ArticleId><ArticleId IdType="pubmed">33053430</ArticleId></ArticleIdList></Reference><Reference><Citation>Rass V, et al. Neurological outcomes one year after COVID-19 diagnosis: a prospective longitudinal cohort study. Eur. J. Neurol. 2022;29:1685&#x2013;1696. doi: 10.1111/ene.15307.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.15307</ArticleId><ArticleId IdType="pmc">PMC9111823</ArticleId><ArticleId IdType="pubmed">35239247</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitaker M, et al. Persistent COVID-19 symptoms in a community study of 606,434 people in England. Nat. Commun. 2022;13:1957. doi: 10.1038/s41467-022-29521-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-29521-z</ArticleId><ArticleId IdType="pmc">PMC9005552</ArticleId><ArticleId IdType="pubmed">35413949</ArticleId></ArticleIdList></Reference><Reference><Citation>Normandin E, et al. Intrathecal inflammatory responses in the absence of SARS-CoV-2 nucleic acid in the CSF of COVID-19 hospitalized patients. J. Neurol. Sci. 2021;430:120023. doi: 10.1016/j.jns.2021.120023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2021.120023</ArticleId><ArticleId IdType="pmc">PMC8489278</ArticleId><ArticleId IdType="pubmed">34678659</ArticleId></ArticleIdList></Reference><Reference><Citation>Etter MM, et al. Severe Neuro-COVID is associated with peripheral immune signatures, autoimmunity and neurodegeneration: a prospective cross-sectional study. Nat. Commun. 2022;13:6777. doi: 10.1038/s41467-022-34068-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-34068-0</ArticleId><ArticleId IdType="pmc">PMC9645766</ArticleId><ArticleId IdType="pubmed">36351919</ArticleId></ArticleIdList></Reference><Reference><Citation>Jarius S, et al. Cerebrospinal fluid findings in COVID-19: a multicenter study of 150 lumbar punctures in 127 patients. J. Neuroinflammation. 2022;19:19. doi: 10.1186/s12974-021-02339-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-021-02339-0</ArticleId><ArticleId IdType="pmc">PMC8771621</ArticleId><ArticleId IdType="pubmed">35057809</ArticleId></ArticleIdList></Reference><Reference><Citation>Hastie CE, et al. Outcomes among confirmed cases and a matched comparison group in the Long-COVID in Scotland study. Nat. Commun. 2022;13:5663. doi: 10.1038/s41467-022-33415-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-33415-5</ArticleId><ArticleId IdType="pmc">PMC9556711</ArticleId><ArticleId IdType="pubmed">36224173</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackman AH, Doty RL. Utility of a three-item smell identification test in detecting olfactory dysfunction. Laryngoscope. 2005;115:2209&#x2013;2212. doi: 10.1097/01.mlg.0000183194.17484.bb.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.mlg.0000183194.17484.bb</ArticleId><ArticleId IdType="pubmed">16369168</ArticleId></ArticleIdList></Reference><Reference><Citation>Lechien JR, et al. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. Eur. Arch. Otorhinolaryngol. 2020;277:2251&#x2013;2261. doi: 10.1007/s00405-020-05965-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00405-020-05965-1</ArticleId><ArticleId IdType="pmc">PMC7134551</ArticleId><ArticleId IdType="pubmed">32253535</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Keeffe E, et al. Dynamic blood&#x2013;brain barrier regulation in mild traumatic brain injury. J. Neurotrauma. 2020;37:347&#x2013;356. doi: 10.1089/neu.2019.6483.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/neu.2019.6483</ArticleId><ArticleId IdType="pmc">PMC10331162</ArticleId><ArticleId IdType="pubmed">31702476</ArticleId></ArticleIdList></Reference><Reference><Citation>Weissberg I, et al. Imaging blood&#x2013;brain barrier dysfunction in football players. JAMA Neurol. 2014;71:1453&#x2013;1455. doi: 10.1001/jamaneurol.2014.2682.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2014.2682</ArticleId><ArticleId IdType="pubmed">25383774</ArticleId></ArticleIdList></Reference><Reference><Citation>Veksler R, et al. Slow blood-to-brain transport underlies enduring barrier dysfunction in American football players. Brain. 2020;143:1826&#x2013;1842. doi: 10.1093/brain/awaa140.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awaa140</ArticleId><ArticleId IdType="pmc">PMC7297017</ArticleId><ArticleId IdType="pubmed">32464655</ArticleId></ArticleIdList></Reference><Reference><Citation>Manj&#xf3;n JV, Coup&#xe9; P. volBrain: an online MRI brain volumetry system. Front. Neuroinform. 2016;10:30. doi: 10.3389/fninf.2016.00030.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fninf.2016.00030</ArticleId><ArticleId IdType="pmc">PMC4961698</ArticleId><ArticleId IdType="pubmed">27512372</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>